Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nuwellis Inc
NUWE
Technology
Scientific & Technical Instruments
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms...
or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NUWE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 11, 2024 8:00am
New Press Release - Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2024.Recent Highlights:Received a 297% CMS...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 05, 2024 9:28am
New Press Release - Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, today announced the entry into definitive agreements for the immediate exercise...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Nov 04, 2024 12:47pm
RE:NUWE.....Start the f'king Drumroll ; )
LoL..... I didn't think so....... just broke the $2.83 support and tapped $2.63...next support at ~ $2.43 Wait for it ; )
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 04, 2024 12:04pm
NUWE.....Start the f'king Drumroll ; )
Support at $2.83.....resistance at $3.30 Something is going to have to break....what's it going to be???? Any guesses from my "faithful Followers" ????
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 04, 2024 11:47am
NUWE....and those last 2 NR's were just a set up to
Exercise 900K warrants @$3.99 Looks like all the a.m Chasers & FOMO's got what they wanted ; ) LoL
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Nov 04, 2024 11:45am
RE:Nuwellis Announces Preliminary Results for Third Quarter of
What that all said was they have $1 million in cash and a Net Loss of ~ $7 million..... Then they post this NR this a.m.......... Nuwellis Receives Increased Reimbursement Rate for
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Nov 01, 2024 8:45pm
Nuwellis Announces Preliminary Results for Third Quarter of
NEWS: $NUWE Nuwellis Announces Preliminary Results for Third Quarter of 2024MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 27, 2024 9:00am
New Press Release - New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy
MINNEAPOLIS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce the publication of a new study in Current Problems in Cardiology demonstrating the effectiveness...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2024 9:00am
New Press Release - Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 13, 2024 8:00am
New Press Release - Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the second quarter ended June 30, 2024. Highlights:Revenue of $2.2 million, a 6...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 08, 2024 9:00am
New Press Release - Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions
MINNEAPOLIS, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload (the “Company”), today announced The Nasdaq Hearings Panel (“Panel”) granted its request to continue its listing on the Nasdaq...
read article.
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 01, 2024 3:03pm
Nuwellis, Inc. (NASDAQ:NUWE): Analysis of a Medical Technolo
https://beyondspx.com/2024/08/01/nuwellis-inc-nasdaqnuwe-analysis-of-a-medical-technology-company/
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 31, 2024 11:41am
NUWE.....Working on scalp #3
Waiting for double digits ; )
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 31, 2024 11:18am
NUWE.....N.H.O.D....then the mini crash
Such is life in the "big league"......Anyone still alive ?
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 31, 2024 10:54am
NUWE....moving up again
Keep the faith Folks
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing